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Polyclonal antibodies raised against he modulator protein of the ATP,Mg-dependent protein phosphatase completely 
neutralize all known properties of the purified modulator: inhibition or inactivation of the phosphatase catalytic subunit 
as well as the kinase F*-mediated activation of the ATP,Mg-dependent phosphatase. They do not cross-react with phos- 
phoinhibitor-1 or the phosphatase catalytic subunit. Direct analysis of boiled or u&oiled skeletal muscle extracts by 
Western blotting reveals a 32 kDa polyp&de corresponding to the modulator protein as the most dominant protein 
staining band. 
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1. INTRODUCTION 
The modulator (M) protein is the thermostable 
regulatory subunit of the cytosolic ATP,Mg- 
dependent protein phosphatase and as such, it 
modulates the transition of the catalytic subunit 
between its active (FE) and inactive (Fc) conforma- 
tion. In the free state (boiled), the modulator also 
causes an instantaneous inhibition of the 
phosphorylase phosphatase activity of the catalytic 
subunit F$. [l]. 
Purification of ‘free’ modulator always includes 
a heat treatment [2] and produces a 32 kDa protein 
on SDS-polyacrylamide gel electrophoresis (SDS- 
PAGE). Its complete primary structure was deter- 
mined recently [3]. The inclusion of the boiling 
step has raised some questions about the native 
structure of the modulator protein in tissue ex- 
tracts [4-71. We have shown that unboiled tissue 
extracts do not contain a ‘free’ modulator, but that 
the modulator activity is always associated in 
higher molecular mass complexes [4-61. Such a 
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complex is the inactive [FcM] enzyme itself, but a 
second modulator containing the [MX] complex 
has been purified and characterized in rabbit 
skeletal muscle [6]. Both complexes were shown to 
contain a 32 kDa modulator subunit complexed to 
a 38 kDa heat-labile protein [4,6]. 
Earlier studies using polyclonal antibodies 
against the modulator protein either provided 
evidence for the existence of a 60 kDa modulator 
protein [7], or suggested that the modulator is pre- 
sent in tissues exclusively as a 32 kDa species [8]. 
In all cases, the antibodies were only shown to 
block the inhibitory properties of the modulator 
protein [7-g], while ATP,Mg-dependent phospha- 
tase activity has been detected in some immuno- 
precipitates [9]. This would suggest that he 
antibodies raised against the free modulator 
recognize the [FcM] enzyme, but do not prevent 
the kinase FA-mediated activation of this inactive 
phosphatase. 
In order to reinvestigate these contradictory and 
confusing results, we produced polyclonal an- 
tibodies against the modulator protein and ex- 
amined their capability to block the different [l] 
modulator activities (activation, inactivation and 
inhibition); Western blotting experiments reveal a 
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32 kDa protein in boiled or unboiled rabbit 
skeletal muscle extracts. 
2. MATERIALS AND METHODS 
2.1. Materials 
Nitrocellulose membranes were purchased from LKB, 
DEAE-Sephacel from Pharmacia, bovine serum albumin from 
Serva and complete Freund’s adjuvant, horseradish peroxidase- 
conjugated rabbit anti-goat IgG, 4-chloro-1-naphthol, trypsin 
and trypsin inhibitor from Sigma. Modulator protein [2], pro- 
tein kinase FA [lo], inactive ATP,Mg-dependent phosphatase 
FcM [6], its active catalytic subunit FE [ll] and inhibitor-l [12] 
were purified from rabbit skeletal muscle. 
The activity of the ATP,Mg-dependent phosphatase was 
commonly measured after a 10 min preincubation at 30°C with 
0.2 mM ATP, 1 mM Mgzf and the minimal amount of kinase 
FA required for full activation. Before the phosphorylase 
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phosphatase assay, a 2 min trypsin treatment was performed, 
followed by the addition of an excess of soybean trypsin in- 
hibitor. The specific activity of the free inactive catalytic 
subunit Fc [13] was 18000 U/mg in the presence and 
1300 U/mg in the absence of an optimal amount of modulator, 
when measured as outlined above. The phosphatase assay time 
was 5 min. One unit of phosphatase releases 1 nmol 
[‘*P]phosphate/min at 30°C from “P-labeled phosphorylase a
(1 mg/ml). 
Inhibitor-l was phosphorylated by the cyclic AMP- 
dependent protein kinase [14] and reisolated by an additional 
boiling step. The bovine heart cyclic AMP-dependent protein 
kinase (catalytic subunit) was a generous gift of D.A. Walsh 
(USA). 
2.2. Methods 
2.2.1. Preparation and purification of antibodies against the 
modulator subunit 
Antibodies against the modulator protein were raised in a 
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Fig.1. Effect of antibodies on the activities of the modulator 
and on the activation of the ATP,Mg-dependent phosphatase 
(FeM). The incubation of 50 ng modulator (A,B) and 100 ng or 
2 U FcM (C) with different amounts of immune (0) and 
preimmune (0) immunoglobulins was done for 30 min on ice 
in a 20~1 incubation mixture. After appropriate dilution, 
modulator activity was assayed as inhibitor of the catalytic 
subunit FE (A) or as activator of Fc (B). Activation of FcM by 
kinase FA was performed as outlined in section 2 (C). Results 
are expressed as the percentage of control phosphatase activity. 
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female goat by injection of homogeneous modulator purified as 
in [2]. Antigen in complete Freund’s adjuvant was injected sub- 
cutaneously at 3-week intervals using 1 mg for the primary and 
0.5 mg for the booster injections. Blood was collected prior to 
immunization and after each injection. The production of an- 
tibodies was determined by Ouchterlony double immunodif- 
fusion. 
Immunoglobulins from antisera and preimmune serum were 
prepared as follows. Blood was allowed to clot and serum was 
collected. Immunoglobulins were precipitated with 40% 
saturated (NH&S04 and the pellet was washed twice in the 
original volume of 40% saturated (NH&S04. The centrifuga- 
tion was repeated, the pellet resuspended in 10 mM Tris-HCl, 
150 mM NaCl at pH 7.4 (buffer A) and extensively dialyzed 
against 10 mM Tris-HCl, pH 8 (buffer B). The sample was 
loaded on a column of DEAB-Sephacel (at least 10 ml bed 
volume for each 100 mg of protein) and washed with buffer B. 
When the absorbance of the eluate at 280 nm reached zero, the 
immunoglobulins were eluted with a linear gradient of 
O-300 mM NaCl in buffer B (volume of the gradient = IO-fold 
the bed volume of the column) and concentrated by dialysis 
against 20% polyethylene glycol in buffer A. The IgG fractions 
were stored in aliquots at - 20°C and used in all subsequent ex- 
periments. Analysis of the preparation by SDS-PAGE showed 
major bands corresponding to the heavy and light chains of im- 
munoglobulin G (not shown). 
2.2.2. Gel electrophoresis, Western transfer and 
immunoblotting 
Polyacrylamide slab gel electrophoresis was performed in the 
presence of SDS, according to the method of Laemmli [lS]. 
Western transfer of proteins onto nitrocellulose membranes was 
done with the Multiphor II Novablot System (LKB), using a 
discontinuous buffer system according to the manufacturers in- 
structions. Following protein transfer, the membrane was in- 
cubated successively with 50 ml quenching solution (5% bovine 
serum albumin in buffer A) for 30 min to block nonspecific 
binding sites, with purified immunoglobulins in 50 ml quen- 
ching solution for 4 h, and with horseradish peroxidase- 
conjugated rabbit anti-goat IgG in 25 ml quench solution for 
40 min. In between incubations the membrane was washed 4 
times for 5 min with 50 ml of buffer A containing 0.1% (v/v) 
Triton X-100 and 2 times for 5 min with 50 ml of buffer A. Im- 
munoreactive bands were then visualized by immersion in a 
mixture of 50 ml buffer A, 12 ml of 0.3% 4-chloro-1-naphthol 
in methanol and 25 ~1 of 30% HrOr. The positions of the 
marker proteins were localized by brief staining with 0.1% 
amido black in 45% methanol/lO% acetic acid. 
3. RESULTS AND DISCUSSION 
The results presented in this study demonstrate 
that the polyclonal antibodies raised in goat 
against he modulator protein are specific in block- 
ing all known modulator activities. Incubation of 
the immunoglobulins with a purified modulator 
preparation resulted in a dose-dependent reduction 
of the modulator activities: inhibition of the 
phosphatase catalytic subunit FE (fig.lA) and of 
the activation of FC (fig.lB). No effects were seen 
when the same sample was incubated with preim- 
mune IgG. Boiling the immunocomplex released 
the heat-stable modulator protein, which exhibited 
both of the activities mentioned above. The an- 
tibodies did not cross-react with phosphoinhibi- 
tor-1 or with the phosphatase catalytic subunit, not 
even when very high concentrations were used 
during incubations with the immunoglobulins (not 
shown). 
The phosphatase catalytic subunit FZ is inac- 
The inactive ATP,Mg-dependent phosphatase 
FcM is activated via a transient phosphorylation of 
the modulator subunit by protein kinase FA, induc- 
ing the isomerization of the catalytic subunit into 
the active conformation [13]. Incubation of FcM 
with the immunoglobulins blocked this activation 
in a dose-dependent manner (fig. 1C). These results 
are in contrast with those presented by other in- 
vestigators who were able to detect ATP,Mg- 
dependent phosphatase activity associated with 
their immunoprecipitates [9]; the reason for this 
discrepancy is not clear. 
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Fig.2. Effect of antibodies on the inactivation of the active 
catalytic subunit (FE) by the modulator protein. Modulator 
(50 ng) was incubated with 80/g of preimmune (0) and 
immune (0) immunoglobulins for 30 min on ice in a 20 ~1 
incubation mixture. An aliquot of this mixture (5 cl) was 
incubated at 30°C with 250 mU of the catalytic subunit FE in 
a 100~1 incubation mixture. A control incubation without 
addition of modulator or immunoglobulins (A) was also 
performed. The phosphorylase phosphatase activity was 
determined at different time intervals after a 2 min trypsin 
treatment. Results are expressed as the percentage of control 
activity. 
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tivated by exogenously added modulator, resulting 
in an enzyme that can be reactivated by kinase FA. 
This inactivation is prevented when enough im- 
munoglobulins are present to complex all the 
modulator (fig.2). These results suggest that the 
antibodies recognize not only both the inhibition 
and the activation site on the modulator protein, 
but also the site where modulator interacts with the 
active catalytic subunit thereby inducing the inac- 
tivation. 
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Fig.3. Effect of antibodies on the modulator activity of a boiled 
skeletal muscle extract and immunoblot analysis. (A) A boiled 
skeletal muscle extract (30 ~1 of 20 mg/ml) was incubated with 
different amounts of immune (0) and preimmune (0) 
immunoglobulins for 30 min on ice in a 40~1 incubation 
mixture. After appropriate dilution, modulator activity was 
assayed as activator of Fc. Results are expressed as percentage 
of control activity. (B) Immunoblot analysis of 40 ng purified 
modulator (lane 1) and of an equivalent amount of unboiled 
(lane 2) and boiled (lane 3) skeletal muscle extract. 
The antibodies inhibit not only the activity of 
purified modulator preparations but also that of 
boiled tissue extracts. Incubation of a boiled 
skeletal muscle extract (10000 x g supernatant 
fraction) with the immunoglobulins resulted in a 
dose-dependent reduction of the modulator activi- 
ty, whereas preimmune IgG did not (fig.3A). 
When a sample of the rabbit skeletal muscle ex- 
tract was subjected to SDS-PAGE, transferred to 
nitrocellulose and probed with the immunoglobu- 
lins, several immunoreactive species were found. A 
32 kDa polypeptide corresponding to the modula- 
tor protein (fig.3B) was always clearly present. 
Boiling the extract did not create new antigenic 
determinants and did not produce an increase in 
the amount of the 32 kDa modulator species. On 
the contrary, boiling the extract always resulted in 
some loss of immunoreactive 32 kDa protein. 
These results provide strong evidence that the 
modulator is indeed present as a 32 kDa protein 
both in unboiled and boiled rabbit skeletal muscle 
extracts. 
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